“…39 More detailed data regarding competitions, impurities, and kinetics of labeling DOTApeptides with 68 Ga were described previously. 18,35 Chemistry of eluate concentration and purification of TiO 2 -based generators was recently summarized by Ocak et al 13 Briefly, there are 3 different methods of purification and/or concentration of 68 Ga: (1) by fractionated elution, (2) by anion chromatography, and (3) by cation chromatography. Fractionated elution results in a ready-to-use eluate containing approximately 80% of the elutable 68 Ga activity.…”
mentioning
confidence: 99%
“…Second, 68 Ge/ 68 Ga generators have been developed that produce suitable eluates for labeling that can be converted into a 68 Galabeled pharmaceutical for PET studies. 8,[10][11][12][13][14][15][16][17] Third, there are many DOTA-peptides that can be labeled with 68 Ga. Fourth, a variety of monofunctional and bifunctional chelators have been developed that allow the formation of stable 68 Ga 3ϩ complexes and convenient coupling to biomolecules. Fifth, the availability of PET radiolabeled pharmaceuticals by the introduction of 68 Ga in radiopharmacy, independent of an on-site cyclotron, opened new applications and possibilities.…”
“…39 More detailed data regarding competitions, impurities, and kinetics of labeling DOTApeptides with 68 Ga were described previously. 18,35 Chemistry of eluate concentration and purification of TiO 2 -based generators was recently summarized by Ocak et al 13 Briefly, there are 3 different methods of purification and/or concentration of 68 Ga: (1) by fractionated elution, (2) by anion chromatography, and (3) by cation chromatography. Fractionated elution results in a ready-to-use eluate containing approximately 80% of the elutable 68 Ga activity.…”
mentioning
confidence: 99%
“…Second, 68 Ge/ 68 Ga generators have been developed that produce suitable eluates for labeling that can be converted into a 68 Galabeled pharmaceutical for PET studies. 8,[10][11][12][13][14][15][16][17] Third, there are many DOTA-peptides that can be labeled with 68 Ga. Fourth, a variety of monofunctional and bifunctional chelators have been developed that allow the formation of stable 68 Ga 3ϩ complexes and convenient coupling to biomolecules. Fifth, the availability of PET radiolabeled pharmaceuticals by the introduction of 68 Ga in radiopharmacy, independent of an on-site cyclotron, opened new applications and possibilities.…”
“…Cation exchange purification HEPES, water for injection HCl concentration <1 M Presence of acetone, formation of mesityloxide [20], [37], [38] Anion exchange purification HEPES, acetate All types Use of concentrated HCl (5.5 M) [31], [32], [36] Fractionation Acetate HCl concentration <1 M 68 Ge breakthrough [21], [33] attraction towards sophisticated automated systems as we have experienced over the last years, may be reconsidered. The possibility of straightforward and rapid radiolabelling at room temperature and labelling at very low pH as recently described for a triazacyclononane-based bifunctional phosphinate [42] could lead to considerable simplification allowing less cost-intensive approaches.…”
Section: Methodsmentioning
confidence: 94%
“…Today most major suppliers of radiosynthesis modules provide systems for 68 Galabelling of peptides. They differ in the postprocessing method employed and are either based on fixed-tubing systems [33,38,39] or, more recently, on single-use cassettes [40] with pharmaceutical advantages in terms of cross-contamination and aseptic handling; however, their costs are higher. These systems provide reliably high yields of typically >60%, in short times.…”
Section: Radiolabelling and Automationmentioning
confidence: 99%
“…The open questions related to these data are clear: What happens in the case of intravenous injection? Cyclotron Co, Obninsk, Russia TiO 2 0.1 M HCl [21], [31], [32], [37] Eckert & Ziegler, Berlin, Germany TiO 2 0.1 M HCl [38], [40] University of Heidelberg, Germany Pyrogallol-formaldehyde resin 5.5 M HCl [5], [31] ITG Isotope Technologies, Garching, Germany Germanium-specific resin 0.05 M HCl [19] In what chemical form will 68 Ge be present in the event of a generator breakthrough? Can it be assumed that 68 Ga produced in situ in organs and tissues will have the same biokinetics as intravenously administered gallium?…”
Section: Availability and Technical Feasibility Of 68 Ge/ 68 Ga Genermentioning
(68)Ga has attracted tremendous interest as a radionuclide for PET based on its suitable half-life of 68 min, high positron emission yield and ready availability from (68)Ge/(68)Ga generators, making it independent of cyclotron production. (68)Ga-labelled DOTA-conjugated somatostatin analogues, including DOTA-TOC, DOTA-TATE and DOTA-NOC, have driven the development of technologies to provide such radiopharmaceuticals for clinical applications mainly in the diagnosis of somatostatin receptor-expressing tumours. We summarize the issues determining the feasibility and availability of (68)Ga-labelled peptides, including generator technology, (68)Ga generator eluate postprocessing methods, radiolabelling, automation and peptide developments, and also quality assurance and regulatory aspects. (68)Ge/(68)Ga generators based on SnO(2), TiO(2) or organic matrices are today routinely supplied to nuclear medicine departments, and a variety of automated systems for postprocessing and radiolabelling have been developed. New developments include improved chelators for (68)Ga that could open new ways to utilize this technology. Challenges and limitations in the on-site preparation and use of (68)Ga-labelled peptides outside the marketing authorization track are also discussed.
In this study a bispidine ligand has been applied to the complexation of gallium(III) and radiolabelled with gallium‐68 for the first time. Despite its 5‐coordinate nature, the resulting complex is stable in serum for over two hours, demonstrating a ligand system well matched to the imaging window of gallium‐68 positron emission tomography (PET). To show the versatility of the bispidine ligand and its potential use in PET, the bifunctional chelator was conjugated to a porphyrin, producing a PET/PDT‐theranostic, which showed the same level of stability to serum as the non‐conjugated gallium‐68 complex. The PET/PDT complex killed >90 % of HT‐29 cells upon light irradiation at 50 μm. This study shows bispidines have the versatility to be used as a ligand system for gallium‐68 in PET.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.